Minister Harris visits European Medicines Agency (EMA)
Today, the Minister for Health, Simon Harris TD, is visiting the European Medicines Agency (EMA) in Canary Wharf in London where he will meet with the Executive Director, Professor Rasi, and members of his team. The Minister will be accompanied by Lorraine Nolan, Chief Executive of the Health Products Regulatory Authority (HPRA, formerly Irish Medicines Board).
The Minister is taking this opportunity to visit the EMA, which is responsible for ensuring that all medicines on the EU market are safe, effective and of high quality.
Speaking ahead of the meeting, the Minister said, “I look forward to meeting with Professor Rasi and his team and discussing the EMA’s vital role in the protection and promotion of public health.
I am also mindful of the consequences of Brexit for the Agency and I believe that it will be essential to minimise the impact of a relocation, in particular by finding a solution that maximises retention of existing staff.
The Government has endorsed my request that Ireland would seek to have the EMA relocate to Dublin.”
In early February the Minister will follow up with a series of meeting with officials and stakeholders in Brussels.
Notes for Editors – About the bid to host the EMA
An interdepartmental/interagency group has been established to develop a detailed proposal to promote the selection of Dublin as the new location for the EMA
- A move to Dublin would minimise the disruption to the business of the EMA, thus ensuring continued protection of EU citizens and providing reassurance to the industries which it regulates.
- Dublin should prove very attractive to EMA staff and their families and maximise retention of existing staff.
- Dublin is an English-speaking location and English is the working language of the EMA and the pharmaceutical industry.
- The Irish medicines regulator – the Health Products Regulatory Authority – would be able to provide strong support to the EMA.